Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 P...

Related Keywords

California ,United States ,Palo Alto ,Germany ,Ahmed Hamdy ,Gabriela Jairala ,Joyce Lonergan ,Ian Flinn ,Exchange Commission ,Nasdaq ,Vincerx Pharma Inc ,Lifesci Advisors ,National Institutes Of Health ,Securities Exchange ,National Institutes ,Chief Executive Officer ,Vincerx Scientific Advisory Board ,Chief Scientific Officer ,Bone Oncology ,Versaptx Platform ,Vincerx Pharma ,Securities Act ,Securities Exchange Act ,Sci Advisors ,